Who
Brent Pfeiffenberger
President and CEO
Company insider
Files Form 4 as: President and CEO, Century Therapeutics; Director, Corbus Pharmaceuticals Holdings; President and CEO, Butterfly Network.
In numbers
- Trades disclosed
- 46
- Buys
- 2
- Sells
- 6
- Bought
- $48K
- Sold
- $60K
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 4 Dec 2023
- Last trade
- 11 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 15 Sep 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $27K13,850 at $1.94 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $27K13,850 at $1.94 | filing |
| 4 Sep 2026filed 9 Sep 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $977463 at $2.11 | filing |
| 4 Sep 2026filed 9 Sep 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $977463 at $2.11 | filing |
| 14 Aug 2026filed 18 Aug 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $60K31,172 at $1.92 | filing |
| 14 Aug 2026filed 18 Aug 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $60K31,172 at $1.92 | filing |
| 11 Jun 2026filed 15 Jun 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $31K13,849 at $2.24 | filing |
| 11 Jun 2026filed 15 Jun 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $31K13,849 at $2.24 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $986463 at $2.13 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $986463 at $2.13 | filing |
| 19 May 2026filed 21 May 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,700 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,700 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $73K31,172 at $2.34 | filing |
| 15 May 2026filed 19 May 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $73K31,172 at $2.34 | filing |
| 11 Mar 2026filed 13 Mar 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $151K55,397 at $2.73 | filing |
| 11 Mar 2026filed 13 Mar 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $151K55,397 at $2.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $1,185463 at $2.56 | filing |
| 6 Mar 2026filed 10 Mar 2026 | IPSC Century TherapeuticsBiotechnology | SEC FORM 4 Code F | $1,185463 at $2.56 | filing |
News
Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in LondonIPSC · manilatimes.net · 14 Oct 2026Century Therapeutics (NASDAQ:IPSC) vs. Burning Rock Biotech (NASDAQ:BNR) Head to Head ContrastIPSC · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Brent Pfeiffenberger; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.